drugset / Trial / NCT03748992
A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
Phase 2
Completed
10 enrolled
Medical University of South Carolina
Cystic Fibrosis Foundation · collabOregon Health and Science University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of open-label exposure of gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed monthly for 3 months.
Timeline
- Start
- 2019-01-28
- Primary completion
- 2020-03-26
- Completion
- 2020-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gNO | Unknown | — | Inhaled |